Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: A potential utility for the evaluation of regional liver function impairment following transcatheter arterial chemoembolization

Xiao,Yu‑Dong; Paudel,Ramchandra; Liu,Huan; Zhang,Bin; Ma,Cong; Zhou,Shun‑Ke

doi:10.3892/ol.2014.2826

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: A potential utility for the evaluation of regional liver function impairment following transcatheter arterial chemoembolization

Authors:
- Yu‑Dong Xiao
- Ramchandra Paudel
- Huan Liu
- Bin Zhang
- Cong Ma
- Shun‑Ke Zhou
View Affiliations

Affiliations: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: December 23, 2014 https://doi.org/10.3892/ol.2014.2826
Pages: 1191-1196

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to evaluate regional liver function impairment following transcatheter arterial chemoembolization (TACE), assessed by magnetic resonance imaging (MRI) enhanced by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd‑EOB‑DTPA). Additionally, this study evaluated the associations between signal intensity and various clinical factors. A prospective study was conducted between March 2012 and May 2013 with a total of 35 patients. Gd‑EOB‑DTPA‑enhanced MRI was performed 3‑5 days after TACE therapy. The signal to noise ratio (SNR) was subsequently calculated for healthy liver tissue regions and peritumoral regions, prior to and 20 min after Gd‑EOB‑DTPA administration. The correlation between clinical factors and relative SNR was assessed using Pearson's correlation coefficient or Spearman's rank correlation coefficient. Prior to Gd‑EOB‑DTPA administration, the SNR values showed no significant difference (t=1.341, P=0.191) in healthy liver tissue regions (50.53±15.99; range, 11.25‑83.46) compared with peritumoral regions (49.81±15.85; range, 12.34‑81.53). On measuring at 20 min following Gd‑EOB‑DTPA administration, the SNR in healthy liver tissue regions (82.55±33.33; range, 31.45‑153.02) was significantly higher (t=3.732, P<0.001) compared with that in peritumoral regions (75.77±27.41; range, 31.42‑144.49). The relative SNR in peritumoral regions correlated only with the quantity of iodized oil used during TACE therapy (r=0.528, P=0.003); the age, gender, diameter and blood supply of the tumor, or Child‑Pugh class of the patient did not correlate with relative SNR. Gd‑EOB‑DTPA‑enhanced MRI may be an effective way to evaluate regional liver function impairment following TACE therapy.

View Figures

View References

1	Liu M, Liu J, Wang L, et al: Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival. Plos One. 9:e1093472014. View Article : Google Scholar : PubMed/NCBI
2	Parikh JG, Kulkarni A and Johns C: α-smooth muscle actin-positive fibroblasts correlate with poor survival in hepatocellular carcinoma. Oncol Lett. 7:573–575. 2014.PubMed/NCBI
3	Guiu B, Minello A, Cottet V, et al: A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 8:986–991. 2010. View Article : Google Scholar : PubMed/NCBI
4	Odisio BC, Galastri F, Avritscher R, et al: Hepatocellular carcinomas within the Milan Criteria: predictors of histologic necrosis after drug-eluting beads transarterial chemoembolization. Cardiovasc Intervent Radiol. 37:1018–1026. 2014. View Article : Google Scholar
5	Le PH, Huang SC, Lim SN, et al: Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma. Oncol Lett. 7:1430–1438. 2014.PubMed/NCBI
6	Choi WJ, Jeong WK, Kim Y, et al: Assessment of treatment success and short-term effectiveness using C-arm CT immediately after hepatic chemoembolization of HCC. Hepatogastroenterology. 61:1353–1358. 2014.PubMed/NCBI
7	Livraghi T, Mäkisalo H and Line PD: Treatment options in hepatocellular carcinoma today. Scand J Surg. 100:22–29. 2011.PubMed/NCBI
8	Llovet JL, Real MI, Montaña X, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 359:1734–1739. 2002. View Article : Google Scholar : PubMed/NCBI
9	Schuette K, Bornschein J, Milbradt O, Mohnike K, Stuebs P and Malfertheiner P: Transarterial chemoembolization (TACE) does have little impact on hepatic metabolic function in patients with hepatocelluar carcinoma (HCC). J Clin Oncol. 29:e145272011.
10	Di Martino M, Marin D, Guerrisi A, et al: Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiol. 256:806–816. 2010. View Article : Google Scholar
11	Nilsson H, Blomqvist L, Douglas L, Nordell A, et al: Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Brit J Radiol. 86:201206532013. View Article : Google Scholar : PubMed/NCBI
12	Katsube T, Okada M, Kumano S, et al: Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 46:277–283. 2011. View Article : Google Scholar : PubMed/NCBI
13	Bae KE, Kim SY, Lee SS, et al: Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis. 30:617–622. 2012. View Article : Google Scholar : PubMed/NCBI
14	Pancholy SB, Sanghvi KA and Patel TM: Radial artery access technique evaluation trial: randomized comparison of seldinger versus modified seldinger technique for arterial access for transradial catheterization. Catheter Cardiovasc Interv. 80:288–291. 2012. View Article : Google Scholar : PubMed/NCBI
15	Huang YS, Chiang JH, Wu JC, Chang FY and Lee SD: Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol. 97:1223–1227. 2002. View Article : Google Scholar : PubMed/NCBI
16	Chen X, Zhang HB, Li ZQ, et al: Indocyanine green clearance in evaluating the recovery of liver reserve function after superselective transarterial chemoembolization. Hepatob Pancreat Dis. 12:656–660. 2013. View Article : Google Scholar
17	Min YW, Lee JH, Gwak GY, et al: Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching. J Gastroen Hepatol. 29:1043–1048. 2014. View Article : Google Scholar
18	Shimizu J, Dono K, Gotoh M, et al: Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci. 44:1330–1337. 1999. View Article : Google Scholar : PubMed/NCBI
19	Yamada A, Hara T, Li F, et al: Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology. 260:727–733. 2011. View Article : Google Scholar : PubMed/NCBI
20	Leonhardt M, Keiser M, Oswald S, et al: Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos. 38:1024–1028. 2010. View Article : Google Scholar : PubMed/NCBI
21	Zhang W, He YJ, Gan Z, et al: OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation. Clin Exp Pharmacol Physiol. 34:1240–1244. 2007. View Article : Google Scholar : PubMed/NCBI
22	Lao XM, Wang D, Shi M, et al: Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepatol Res. 41:553–563. 2011. View Article : Google Scholar : PubMed/NCBI
23	Saito M, Seo Y, Yano Y, et al: Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. J Gastroenterol. 47:704–714. 2012. View Article : Google Scholar : PubMed/NCBI
24	Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al: Preclinial evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 183:59–64. 1992. View Article : Google Scholar : PubMed/NCBI
25	Planchamp C, Montet X, Frossard JL, et al: Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers. Invest Radiol. 40:187–194. 2005. View Article : Google Scholar : PubMed/NCBI
26	Kim HY, Choi JY, Park CH, et al: Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. J Gastroenterol. 48:1180–1187. 2013. View Article : Google Scholar : PubMed/NCBI
27	Kanki A, Tamada T, Higaki A, et al: Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis. Magn Reson Imaging. 30:356–360. 2012. View Article : Google Scholar : PubMed/NCBI
28	Motosugi U, Ichikawa T, Sou H, et al: Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging. 30:1042–1046. 2009. View Article : Google Scholar : PubMed/NCBI
29	Utsunomiya T, Shimada M, Hanaoka J, et al: Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve. J Gastroenterol. 47:470–476. 2012. View Article : Google Scholar
30	Goshima S, Kanematsu M, Watanabe H, et al: Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio. J Magn Reson Imaging. 36:1148–1153. 2012. View Article : Google Scholar : PubMed/NCBI
31	Takao H, Akai H, Tajima T, et al: MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol. 77:325–329. 2011. View Article : Google Scholar
32	Bickelhaupt S, Studer P, Kim-Fuchs C, et al: Gadoxetate uptake as a possible marker of hepatocyte damage after liver resection-preliminary data. Clin Radiol. 68:1121–1127. 2013. View Article : Google Scholar : PubMed/NCBI
33	Goel A, Mehta N, Guy J, et al: Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 20:1221–1228. 2014. View Article : Google Scholar : PubMed/NCBI
34	Negi SS and Chaudhary A: Analysis of abnormal recovery pattern of liver function tests after surgical repair of bile duct strictures. J Gastroenterol Hepatol. 20:1533–1537. 2005. View Article : Google Scholar : PubMed/NCBI